DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | MGAT4A | 11320 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Q9UM21 |
C1306459 | Primary malignant neoplasm | MGAT4B | 11282 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B | Q9UQ53 |
C1269683 | Major Depressive Disorder | MGAT4B | 11282 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B | Q9UQ53 |
C0006826 | Malignant Neoplasms | MGAT4B | 11282 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B | Q9UQ53 |
C0235974 | Pancreatic carcinoma | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0346647 | Malignant neoplasm of pancreas | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0006826 | Malignant Neoplasms | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0030297 | Pancreatic Neoplasm | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0017152 | Gastritis | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0030920 | Peptic Ulcer | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0278701 | Gastric Adenocarcinoma | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C1306459 | Primary malignant neoplasm | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0699791 | Stomach Carcinoma | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0024623 | Malignant neoplasm of stomach | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0001418 | Adenocarcinoma | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C2931008 | Congenital disorder of glycosylation type 2A | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0025517 | Metabolic Diseases | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0036572 | Seizures | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0028754 | Obesity | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0282577 | Congenital Disorders of Glycosylation | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0018784 | Sensorineural Hearing Loss (disorder) | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0027651 | Neoplasms | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0016202 | Flatfoot | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0085207 | Gestational Diabetes | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
C0011847 | Diabetes | MGAT2 | 4247 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Q10469 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024